US EditionCDC Panel Recommends GSK's New PENMENVY Vaccine for Adolescents
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
CDC Panel Recommends GSK's New PENMENVY Vaccine for Adolescents
PHILADELPHIA, PA — The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the inclusion of GSK’s PENMENVY vaccine in the adolescent meningococcal vaccination schedule. The decision marks a significant advance in the prevention of meningococcal disease caused by serogroups A, B, C, W, and Y. PENMENVY, recently approved by the U.S. Food and Drug Administration (FDA) for use i…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
